Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.890
+0.040 (1.40%)
At close: Nov 4, 2024, 4:00 PM
2.929
+0.039 (1.35%)
After-hours: Nov 4, 2024, 6:33 PM EST

Sunshine Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
67143050
Upgrade
Market Cap Growth
-34.95%-51.77%-52.26%480.17%1941.74%-79.87%
Upgrade
Enterprise Value
-5-11-263261
Upgrade
Last Close Price
2.84543.001280.0023380.006280.003600.00
Upgrade
PE Ratio
--1.43----
Upgrade
PS Ratio
0.000.293.33132.5573.0812.10
Upgrade
PB Ratio
0.140.330.67143.04-5.47-0.35
Upgrade
P/FCF Ratio
-0.68-0.79-2.66-16.55-7.93-0.51
Upgrade
P/OCF Ratio
-0.72-0.79-2.75-16.55-7.94-0.52
Upgrade
EV/Sales Ratio
-0.29-0.46-6.01137.9881.7647.12
Upgrade
EV/EBITDA Ratio
2.022.423.02-12.98-10.37-1.59
Upgrade
EV/EBIT Ratio
1.952.343.01-12.92-10.12-1.55
Upgrade
EV/FCF Ratio
0.771.264.80-17.23-8.87-2.00
Upgrade
Debt / Equity Ratio
0.020.030.048.98-2.00-0.97
Upgrade
Debt / FCF Ratio
-0.05-0.07-0.14-1.04-2.91-1.44
Upgrade
Asset Turnover
1.060.850.280.140.120.03
Upgrade
Inventory Turnover
3.333.491.561.821.30-
Upgrade
Quick Ratio
2.923.393.4222.590.950.06
Upgrade
Current Ratio
4.864.483.9424.070.980.08
Upgrade
Return on Equity (ROE)
-15.79%-21.04%-244.92%---
Upgrade
Return on Assets (ROA)
-9.91%-10.57%-34.48%-93.90%-63.05%-64.44%
Upgrade
Return on Capital (ROIC)
-11.94%-13.52%-44.25%-99.36%-76.84%-91.45%
Upgrade
Earnings Yield
-64.79%-64.63%-185.03%-41.08%-53.35%-649.57%
Upgrade
FCF Yield
-203.81%-127.05%-37.65%-6.04%-12.62%-194.31%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.